We are analyzing https://link.springer.com/article/10.1007/bf01806383.

Title:
Analysis of interval breast carcinomas in a randomized screening trial in Stockholm | Breast Cancer Research and Treatment
Description:
In the interval between screening examinations, some cases of breast cancer are invariably detected clinically in patients whose mammogram was considered to be normal at the earlier screening. During the first interval in the Stockholm study, 60 interval cancers were detected, giving a rate of 1.8 cases/1000 examinations/24 months. About half of these interval cases (31/60) were true interval tumours in that no sign of them could be found on the first mammogram; the other half, non-true, were possible to trace on the first mammogram. It is mainly women under 50 who feature in the interval group, above all in the sub-group of true interval cancers (p<0.05). The incidence of interval cancer rises, as expected, with the length of the interval (Fig. 1). In the final six months of the 2-year interval the incidence of interval cancers had risen to 88 per cent of the cancers detected in the control group in the same period of time. The cumulative incidence of interval cancers supports the hypothesis that the distribution of sojourn time in the interval 0–2 years is approximately rectangular. This means that shortening the interval by one-half would halve the number of interval cases. If mammography becomes a wide spread screening method for early detection of breast cancer, the number of non-true interval cancers could be a feed back on the effectiveness of the screening. An analysis of the malignancy of the true interval cancers, based on tumour size, axillary status, tumour stage, and estrogen receptor content, shows that these are the more malignant tumours with an unfavourable prognosis, while the control group is intermediate in this respect and the tumours detected at screening have the most favourable prognosis.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Music
Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

cancer, breast, interval, google, scholar, screening, pubmed, cancers, article, stockholm, analysis, mammography, sweden, privacy, cookies, content, research, hellström, res, publish, search, carcinomas, randomized, frisell, eklund, somell, cases, detected, prognosis, access, data, information, log, journal, trial, mammogram, true, tumours, group, incidence, tumour, axillary, receptor, discover, results, heuser, spratt, buchanan, mammographic, growth,

Topics {✒️}

month download article/chapter cancer epidemiology breast cancer screening breast cancer missed advanced breast cancer interval breast cancer privacy choices/manage cookies early detection interval cancer rises estradiol receptor analysis mass screening programmes interval breast carcinomas randomized mammographic screening single view mammography axillary node metastasis full article pdf randomized screening trial breast cancer european economic area estrogen receptor content �fast’ growth rates karolinska university hospital called interval cancers cancer res 38 conditions privacy policy estrogen receptor status interval cancers supports accepting optional cookies invariably detected clinically polk jr ho true interval cancers true interval cancers true interval tumours check access instant access stockholm report published journal finder publish mammography screening article frisell heuser ls usage analysis screening examinations unfavourable prognosis favourable prognosis related subjects gustafsson sa affiliations departments breast neoplasias earlier screening population screening

Questions {❓}

Andersson I: What can we learn from interval carcinomas?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Analysis of interval breast carcinomas in a randomized screening trial in Stockholm
         description:In the interval between screening examinations, some cases of breast cancer are invariably detected clinically in patients whose mammogram was considered to be normal at the earlier screening. During the first interval in the Stockholm study, 60 interval cancers were detected, giving a rate of 1.8 cases/1000 examinations/24 months. About half of these interval cases (31/60) were true interval tumours in that no sign of them could be found on the first mammogram; the other half, non-true, were possible to trace on the first mammogram. It is mainly women under 50 who feature in the interval group, above all in the sub-group of true interval cancers (p<0.05). The incidence of interval cancer rises, as expected, with the length of the interval (Fig. 1). In the final six months of the 2-year interval the incidence of interval cancers had risen to 88 per cent of the cancers detected in the control group in the same period of time. The cumulative incidence of interval cancers supports the hypothesis that the distribution of sojourn time in the interval 0–2 years is approximately rectangular. This means that shortening the interval by one-half would halve the number of interval cases. If mammography becomes a wide spread screening method for early detection of breast cancer, the number of non-true interval cancers could be a feed back on the effectiveness of the screening. An analysis of the malignancy of the true interval cancers, based on tumour size, axillary status, tumour stage, and estrogen receptor content, shows that these are the more malignant tumours with an unfavourable prognosis, while the control group is intermediate in this respect and the tumours detected at screening have the most favourable prognosis.
         datePublished:
         dateModified:
         pageStart:219
         pageEnd:225
         sameAs:https://doi.org/10.1007/BF01806383
         keywords:
            breast cancer
            mammography
            screening
            interval cancer
            prognosis
            Oncology
         image:
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:9
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Martinus Nijhoff/Dr. W. Junk Publishers
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Jan Frisell
               affiliation:
                     name:Södersjukhuset
                     address:
                        name:Departments of Surgery, Södersjukhuset, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gunnar Eklund
               affiliation:
                     name:Karolinska University Hospital
                     address:
                        name:Department of Cancer Epidemiology, Karolinska University Hospital, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lars Hellström
               affiliation:
                     name:Södersjukhuset
                     address:
                        name:Departments of Radiology, Södersjukhuset, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Anders Somell
               affiliation:
                     name:Södersjukhuset
                     address:
                        name:Departments of Surgery, Södersjukhuset, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Analysis of interval breast carcinomas in a randomized screening trial in Stockholm
      description:In the interval between screening examinations, some cases of breast cancer are invariably detected clinically in patients whose mammogram was considered to be normal at the earlier screening. During the first interval in the Stockholm study, 60 interval cancers were detected, giving a rate of 1.8 cases/1000 examinations/24 months. About half of these interval cases (31/60) were true interval tumours in that no sign of them could be found on the first mammogram; the other half, non-true, were possible to trace on the first mammogram. It is mainly women under 50 who feature in the interval group, above all in the sub-group of true interval cancers (p<0.05). The incidence of interval cancer rises, as expected, with the length of the interval (Fig. 1). In the final six months of the 2-year interval the incidence of interval cancers had risen to 88 per cent of the cancers detected in the control group in the same period of time. The cumulative incidence of interval cancers supports the hypothesis that the distribution of sojourn time in the interval 0–2 years is approximately rectangular. This means that shortening the interval by one-half would halve the number of interval cases. If mammography becomes a wide spread screening method for early detection of breast cancer, the number of non-true interval cancers could be a feed back on the effectiveness of the screening. An analysis of the malignancy of the true interval cancers, based on tumour size, axillary status, tumour stage, and estrogen receptor content, shows that these are the more malignant tumours with an unfavourable prognosis, while the control group is intermediate in this respect and the tumours detected at screening have the most favourable prognosis.
      datePublished:
      dateModified:
      pageStart:219
      pageEnd:225
      sameAs:https://doi.org/10.1007/BF01806383
      keywords:
         breast cancer
         mammography
         screening
         interval cancer
         prognosis
         Oncology
      image:
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:9
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Martinus Nijhoff/Dr. W. Junk Publishers
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Jan Frisell
            affiliation:
                  name:Södersjukhuset
                  address:
                     name:Departments of Surgery, Södersjukhuset, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gunnar Eklund
            affiliation:
                  name:Karolinska University Hospital
                  address:
                     name:Department of Cancer Epidemiology, Karolinska University Hospital, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lars Hellström
            affiliation:
                  name:Södersjukhuset
                  address:
                     name:Departments of Radiology, Södersjukhuset, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Anders Somell
            affiliation:
                  name:Södersjukhuset
                  address:
                     name:Departments of Surgery, Södersjukhuset, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:9
Organization:
      name:Martinus Nijhoff/Dr. W. Junk Publishers
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Södersjukhuset
      address:
         name:Departments of Surgery, Södersjukhuset, Stockholm, Sweden
         type:PostalAddress
      name:Karolinska University Hospital
      address:
         name:Department of Cancer Epidemiology, Karolinska University Hospital, Stockholm, Sweden
         type:PostalAddress
      name:Södersjukhuset
      address:
         name:Departments of Radiology, Södersjukhuset, Stockholm, Sweden
         type:PostalAddress
      name:Södersjukhuset
      address:
         name:Departments of Surgery, Södersjukhuset, Stockholm, Sweden
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Jan Frisell
      affiliation:
            name:Södersjukhuset
            address:
               name:Departments of Surgery, Södersjukhuset, Stockholm, Sweden
               type:PostalAddress
            type:Organization
      name:Gunnar Eklund
      affiliation:
            name:Karolinska University Hospital
            address:
               name:Department of Cancer Epidemiology, Karolinska University Hospital, Stockholm, Sweden
               type:PostalAddress
            type:Organization
      name:Lars Hellström
      affiliation:
            name:Södersjukhuset
            address:
               name:Departments of Radiology, Södersjukhuset, Stockholm, Sweden
               type:PostalAddress
            type:Organization
      name:Anders Somell
      affiliation:
            name:Södersjukhuset
            address:
               name:Departments of Surgery, Södersjukhuset, Stockholm, Sweden
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Departments of Surgery, Södersjukhuset, Stockholm, Sweden
      name:Department of Cancer Epidemiology, Karolinska University Hospital, Stockholm, Sweden
      name:Departments of Radiology, Södersjukhuset, Stockholm, Sweden
      name:Departments of Surgery, Södersjukhuset, Stockholm, Sweden
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(65)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Angular
Clipboard.js
Prism.js

CDN Services {📦}

Crossref

3.74s.

LINK . SPRINGER . COM {}